Efficacy of two telemonitoring systems to improve glycaemic control during basal insulin initiation in patients with type 2 diabetes: The TeleDiab-2 randomized controlled trial
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Efficacy of two telemonitoring systems to improve glycaemic control during basal insulin initiation in patients with type 2 diabetes: The TeleDiab-2 randomized controlled trial |
| Type de publication | Journal Article |
| Year of Publication | 2019 |
| Auteurs | Franc S, Joubert M, Daoudi A, Fagour C, Benhamou P-Y, Rodier M, Boucherie B, Benamo E, Schaepelynck P, Guerci B, Dardari D, Borot S, Penfornis A, D'Orsay G, Mari K, Reznik Y, Randazzo C, Charpentier G, Grp TDStudy |
| Journal | DIABETES OBESITY & METABOLISM |
| Volume | 21 |
| Pagination | 2327-2332 |
| Date Published | OCT |
| Type of Article | Article |
| ISSN | 1462-8902 |
| Mots-clés | basal insulin, Glycaemic control, insulin therapy, Randomized trial, Type 2 diabetes |
| Résumé | {TeleDiab-2 was a 13-month randomized controlled trial evaluating the efficacy and safety of two telemonitoring systems to optimize basal insulin (BI) initiation in subjects with inadequately controlled type 2 diabetes (HbA1c, 7.5%-10%). A total of 191 participants (mean age 58.7 years, mean HbA1c 8.9%) were randomized into three groups: group 1(G1, standard care |
| DOI | 10.1111/dom.13806 |